Navigation Links
Health Diagnostic Laboratory Inc. Sponsors Lecture Series in West Palm Beach, Florida
Date:6/27/2011

RICHMOND, Va., June 27, 2011 /PRNewswire/ -- A Continuing Medical Education (CME) workshop, Beating Cardiovascular Disease:  Understanding the meaning and value of key risk factors, will be hosted at the Chesterfield Hotel in West Palm Beach, Florida, on July 9, 2011 from 8:30am to 1pm.

"Beating Cardiovascular Disease, a free course with four Continuing Medical Education credits, is designed to help doctors eradicate this disease in their practice based upon new and future developments in advanced testing," said Dr. Sam Fillingane, who will lead the course.

This interactive, four-hour session is a free Continuing Medical Education course with four CME credits available by AAFP. Specific clinical cases will be profiled that will demonstrate evaluation and treatment regimens of specific types of cardiovascular patients commonly seen in primary care practices. Ischemic heart disease, strokes, and cardiomyopathy patients will be discussed, along with how each case progressed with the help of advanced cardiovascular data assistance. Clinicians will discuss as a group how they would treat example cases, with emphasis on biomarker identification and resulting clinical implications.  

The lecture series aims to educate clinicians on the meaning and value of key risk factors directly related to the diagnosis and treatment of cardiovascular disease, clinical strategies that will help make use of cardiovascular marker information, and the cardiovascular diagnostic tools that are available. Dr. Fillingane will also share practical clinical advice on improving cardiovascular outcomes of patients at risk using methods of evaluation to minimize the possibility of patients "slipping through the cracks." Interested physicians should RSVP to 1-877-443-5227 by July 5.

Cardiovascular disease is the number one killer of people in the United States, killing more people than the next four causes of death combined. Beating Cardiovascular Disease:  Understanding the meaning and value of key risk factors is an ongoing series of workshops designed to change this statistic. In addition to the CME course in West Palm Beach on July 9, training for family practitioners and other medical leaders will be offered in Charlotte, Raleigh, Greenville, Atlanta, Richmond, Idaho Falls and more throughout the summer of 2011.

About HDL, Inc.  

Health Diagnostic Laboratory Inc. (HDL, Inc., www.myhdl.com), a CAP accredited leader in health management, offers a comprehensive test menu of risk factors and biomarkers for cardiovascular and related diseases. Our systematic approach identifies factors contributing to disease and provides a basis for effective treatment, allowing physicians to more effectively manage patients.  As an added value, patients receive a personalized overview of their risk factors along with intensive counseling from expert Health Coaches at no additional cost, improving compliance and enhancing satisfaction.


'/>"/>
SOURCE HDL, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. CMHC/MIS Electronic Health Record Solution from Netsmart Technologies Attains Complete ARRA Certification
2. Careers in Healthcare and Science? "Not Interested" Say Half of U.S. Teens
3. Health Technology Assessment Goes Online
4. New Online Training Course Helps Healthcare Vendors Comply with HIPAA Regulations
5. PAREXEL International to Present at Wells Fargo Healthcare Conference
6. Healthpoint Biotherapeutics Acquires Regranex® Gel
7. Halozyme Therapeutics to Present at the Jefferies 2011 Global Healthcare Conference on June 9
8. Questcor Pharmaceuticals to Present at the Jefferies Global Healthcare Conference on June 9, 2011
9. Lexicon Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
10. Amylin Pharmaceuticals to Present at Goldman Sachs 32nd Annual Global Healthcare Conference and Jefferies Global Life Sciences Conference
11. Avanir Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... ... has validated a 0.2 ng/mL lower limit (LLOQ) assay for nicotine and two ... LLOQ assay, the ultra-low trace nicotine assay meets additional needs of tobacco industry ...
(Date:4/27/2017)... ... 2017 , ... Oncolinx, a spin-out of the Center for ... taken their cancer research out of this world. On April 22, 2017, an ... the International Space Station’s (ISS) U.S. National Laboratory, managed by the Center for ...
(Date:4/27/2017)... ... , ... Mitotech S.A, a Luxembourg based clinical stage biotechnology company, announced positive ... a rare devastating genetic disease that leads to a sudden and rapid loss of ... patients carrying 11778, 14484 and 3460 mutations and having experienced the onset of symptoms ...
(Date:4/27/2017)... ... April 27, 2017 , ... Arrowhead ... ( http://www.paintherapeuticsummit.com ) is coming to San Diego, CA on September 27-28, 2017. ... learn about the latest advances in the treatment of various types of pain. ...
Breaking Biology Technology:
(Date:4/13/2017)... MONICA, Calif. , April 13, 2017 ... New York will feature emerging and evolving ... Summits. Both Innovation Summits will run alongside the expo ... of speaker sessions, panels and demonstrations focused on trending ... coast,s largest advanced design and manufacturing event will take ...
(Date:4/11/2017)... 2017 NXT-ID, Inc. (NASDAQ:   NXTD ... the appointment of independent Directors Mr. Robin D. Richards ... of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief ... to their guidance and benefiting from their considerable expertise as ...
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
Breaking Biology News(10 mins):